FDA issued a Warning Letter to Baxter Healthcare Corporation on 5/31/2013 for a previous inspection.
483 Baxter Healthcare May 2015

483 Baxter Healthcare May 2015

Jose Melendez FDA$119.00 - Available Now

FDA investigators audited the Baxter Healthcare - Jayuya, PR, United States facility and issued 3 inspectional observations (via FDA 483) on 01 May 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 01 May 2015
  • Location: Jayuya, United States
  • FEI: 2618677
Add To Cart